Controversies with testosterone therapy.
CONCLUSIONS: Clinicians prescribing testosterone should be aware of the current controversies associated with TTh. The current literature does not suggest that there is a significant risk with TTh and prostate cancer, worsening of BPH symptoms or CV events. However, more studies, including randomized placebo-controlled trials, are needed. Finally, patients should be counseled appropriately regarding the indications for TTh and the benefits of lifestyle modification prior to initiating TTh.
PMID: 32875998 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
More News: Benign Prostatic Hyperplasia | Canada Health | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Low Testosterone | Prostate Cancer | Sleep Disorders | Sleep Medicine | Study | Urology & Nephrology